Forecast & Rating2 analysts currently cover Traws Pharma, of which 0 give a positive rating. The average price target is $1.00, about 81.8% upside from the current price of $0.55. Coverage is limited, so the data is for reference only. Data as of Aug 18, 2026; this does not constitute investment advice.
Aug 18, 2026Price forecast
$1.0081.79%
Forecast & RatingHold
2analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 31, 2026
Forecast met8.3%
Stock price$0.55
Avg. target$8.0
High target$8
Low target$8
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.